Nabla

Nabla is a health technology company that develops an ambient artificial intelligence assistant for clinicians, generating structured clinical notes and medical codes in real time from doctor-patient conversations and integrating the output into electronic health record systems. The company was founded in 2018 by Alexandre Lebrun, Delphine Groll, and Martin Raison, and is headquartered in Paris, France, with a growing presence in the United States.

The company's core product is an ambient scribe, marketed as Nabla Copilot, that listens to a consultation and drafts documentation, dictation, and coding for the clinician to review. The system integrates with major EHR platforms and supports more than 35 languages. Nabla is deployed across 190+ health organizations and used by more than 100,000 clinicians, positioning it among the more widely adopted vendors in the ambient clinical documentation market alongside competitors such as Abridge and Microsoft-owned Nuance DAX.

Nabla raised a $24 million Series B in January 2024, followed by a $70 million Series C announced in June 2025 that was led by HV Capital with participation from Highland Europe, DST Global, Cathay Innovation, and Tony Fadell's Build Collective. The Series C brought total funding to $120 million. The company employs an estimated 51 to 200 people and has used its capital to expand agentic AI features and grow its footprint in the U.S. healthcare market.